國立虎尾科技大學 |

Mechanisms of Drug Resistance in Cancer Therapy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Mechanisms of Drug Resistance in Cancer Therapy/ edited by Mario Mandalà, Emanuela Romano.
other author:	Mandalà, Mario.
Description:	VIII, 297 p. 32 illus., 31 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Pharmacology. -
Online resource:	https://doi.org/10.1007/978-3-030-10507-5
ISBN:	9783030105075

Mechanisms of Drug Resistance in Cancer Therapy
Mechanisms of Drug Resistance in Cancer Therapy[electronic resource] /edited by Mario Mandalà, Emanuela Romano. - 1st ed. 2018. - VIII, 297 p. 32 illus., 31 illus. in color.online resource. - Handbook of Experimental Pharmacology,2490171-2004 ;. - Handbook of Experimental Pharmacology,224.

1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm -- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival -- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies -- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer -- 5. Mechanisms of Drug Resistance in Melanoma -- 6. Mechanisms of Resistance to Immune Checkpoint Antibodies -- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma -- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer -- 9. Targeting DNA repair -- 10. Resistance to Hormonal Therapy in Prostate Cancer -- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors -- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia -- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia -- 14. Mechanisms of Resistance in Multiple Myeloma -- 15. Cancer Evolution as the New Frontier of Precision.

A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.

ISBN: 9783030105075

Standard No.: 10.1007/978-3-030-10507-5doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM1-950

Dewey Class. No.: 615

Mechanisms of Drug Resistance in Cancer Therapy
LDR:02955nam a22003975i 4500 001 991522
003 DE-He213
005 20200629164906.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783030105075 $9 978-3-030-10507-5
024 7 $a 10.1007/978-3-030-10507-5 $2 doi
035 $a 978-3-030-10507-5
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 0 $a Mechanisms of Drug Resistance in Cancer Therapy $h [electronic resource] / $c edited by Mario Mandalà, Emanuela Romano.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a VIII, 297 p. 32 illus., 31 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 249
505 0 $a 1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm -- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival -- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies -- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer -- 5. Mechanisms of Drug Resistance in Melanoma -- 6. Mechanisms of Resistance to Immune Checkpoint Antibodies -- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma -- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer -- 9. Targeting DNA repair -- 10. Resistance to Hormonal Therapy in Prostate Cancer -- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors -- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia -- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia -- 14. Mechanisms of Resistance in Multiple Myeloma -- 15. Cancer Evolution as the New Frontier of Precision.
520 $a A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.
650 0 $a Pharmacology. $3 583819
650 0 $a Cancer research. $3 1253664
650 0 $a Drug resistance. $3 872072
650 0 $a Molecular biology. $3 583443
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Drug Resistance. $3 782695
650 2 4 $a Molecular Medicine. $3 668353
700 1 $a Mandalà, Mario. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1283186
700 1 $a Romano, Emanuela. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1211534
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030105068
776 0 8 $i Printed edition: $z 9783030105082
830 0 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224 $3 1254015
856 4 0 $u https://doi.org/10.1007/978-3-030-10507-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)